Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linperlisib in Combination With CHOP in Previously Untreated Peripheral T-Cell Lymphoma
NCT05949944Phase 2Active, not recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Aug 2023
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of linperlisib in peripheral T-cell lymphoma (PTCL), sponsored by Sun Yat-sen University. Started Aug 2023; status: active, not recruiting.
02
Drugs
linperlisib
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT05949944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05949944.